Clinical Scorecard: Wearable, Physiotherapy-Guided Exercise Combination Could Show Benefit in T2D
At a Glance
| Category | Detail |
|---|---|
| Condition | Type 2 Diabetes (T2D) with Diabetic Kidney Disease |
| Key Mechanisms | Physiotherapist-guided exercise combined with wearable device feedback |
| Target Population | Outpatients with type 2 diabetes and diabetic kidney disease |
| Care Setting | Outpatient physiotherapy and multidisciplinary care |
Key Highlights
- Intervention group showed a 39-m increase in 6-minute walk distance
- Glycated hemoglobin decreased by 0.89 percentage points in the intervention group
- No adverse events related to the intervention were reported
- Adherence to exercise was feasible with 20 of 25 patients exercising at least three times per week
- No significant difference in estimated glomerular filtration rate between groups
Guideline-Based Recommendations
Diagnosis
- Monitor 6-minute walk distance as a measure of exercise capacity
Management
- Implement physiotherapist-guided exercise with wearable feedback for T2D patients
Monitoring & Follow-up
- Regularly assess glycated hemoglobin and exercise adherence
Risks
- Caution in interpreting renal findings due to potential influence of muscle mass on creatinine estimates
Patient & Prescribing Data
Outpatients with type 2 diabetes and diabetic kidney disease
Combination of physiotherapy and wearable technology improves exercise capacity and metabolic outcomes
Clinical Best Practices
- Encourage gradual increase in physical activity by at least 500 steps above baseline
- Utilize data from wearable devices to tailor exercise plans during physiotherapy sessions
- Monitor for potential adverse events and ensure patient safety during exercise
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
